Becton, Dickinson and Company

Becton, Dickinson and Company (BDX) develops, manufactures, and sells a broad range of medical supplies, devices, laboratory equipment, and diagnostic products. Its portfolio includes peripheral intravenous catheters, central lines, acute dialysis catheters, vascular access technology, needle-free IV connectors, closed-system drug transfer devices, hypodermic syringes and needles, anesthesia needles and trays, and sharps disposal systems. The company also offers IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, informatics and analytics, pharmacy automation systems, hemodynamic monitoring systems, and prefillable drug delivery systems. Additionally, BDX provides specimen and blood collection products, automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility testing, rapid diagnostic assays, microbiology laboratory automation products, plated media products, and fluorescence-activated cell sorters and analyzers, antibodies and kits, and reagent systems.

Becton, Dickinson and Company (BDX) is listed on the New York Stock Exchange (NYSE) and trades in US Dollars (USD). As a US-based company, its stock is denominated in the local currency, making it accessible to investors on the NYSE under the ticker symbol BDX.

Becton, Dickinson and Company (BDX) operates in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. This means the company is involved in the development and manufacturing of medical devices, instruments, and supplies used by healthcare providers, laboratories, and pharmaceutical companies. Its products range from basic syringes and needles to advanced diagnostic equipment and medication management systems.

Becton, Dickinson and Company (BDX) organizes its business into five segments: Medical Essentials, Connected Care, BioPharma Systems, Interventional, and Life Sciences. The Medical Essentials segment includes peripheral IV catheters, hypodermic syringes, and sharps disposal systems. Connected Care focuses on IV medication safety and infusion therapy delivery systems, medication compounding workflow, and automated medication dispensing. BioPharma Systems provides prefillable drug delivery systems and closed-system drug transfer devices. Interventional offers vascular access technology and hemodynamic monitoring systems. Life Sciences includes diagnostic products such as blood culturing, molecular testing, and microbiology laboratory automation.

Becton, Dickinson and Company (BDX) serves a diverse customer base globally, including healthcare institutions such as hospitals and clinics, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Its products are used in various settings, from routine blood collection and IV therapy to advanced diagnostic testing and drug delivery systems. The company's broad portfolio addresses the needs of medical professionals and researchers across multiple healthcare and life science disciplines.